Second mechanism of action discovered for COVID-19 drug remdesivir
Researchers have found that a metabolite of remdesivir potentially targets a SARS-CoV-2 protein involved in suppressing the host cell's defence response.
List view / Grid view
Researchers have found that a metabolite of remdesivir potentially targets a SARS-CoV-2 protein involved in suppressing the host cell's defence response.
Researchers have shown that topoisomerase TOP2A eliminates negative supercoiling, causing an increase in the number of turns of DNA strands and impacting gene expression.
Researchers have revealed which genes are switched on or off in osteocytes, a bone cell found in the skeleton.
Scientists have created a new nanopore sequencing platform that can detect the presence of the nucleobases of DNA.
Researchers have shown that an mRNA delivery system can be used to produce the BDNF protein in rats to protect neurons from ischemia.
Researchers have created a new single-cell transcriptomics approach that cryopreserves cells, limiting the stress they are put under.
Researchers have shown that miR-29 can control brain maturation in mammals, presenting a target for autism, epilepsy and other conditions.
Sahm Nasseri discusses promising pre-clinical results of an RNA-based therapeutic developed to treat retinitis pigmentosa type 11.
In this application note, discover how pools of synthetic crRNAs can produce a phenotype as strong as, or stronger, than any one of the component crRNAs in arrayed CRISPR screening experiments.
Promising results have been shown in an animal model of Alzheimer's disease treated with zinc finger protein transcription factors.
SARS-CoV-2 diverts building blocks from glucose production to the assembly of purine bases, researchers have found.
A team has revealed a function of ADAR1, responsible for RNA editing, discovering an isoform used for cancer growth, making it a drug target.
Sequencing and transcriptome data on iPSCs has been used to identify correlations between genetic variants and expression patterns.
Researchers have developed a new technique called mim-tRNAseq to measure, map and analyse tRNAs in cells, providing insight into disease.
A fluorescence imaging technique has allowed scientists to observe RNA in real time using single-molecule localisation microscopy.